IAIM
VBIV

International Assets Investment Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

International Assets Investment Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3
Closed – – 2008
2021
Q1 		$0 Buy
+3
New +$304 ﹤0.01% 2221

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

International Assets Investment Management's VBIV Position: Q2 2021 in Review

International Assets Investment Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2021, closing a stake of 3 shares.

International Assets Investment Management first reported a position in VBIV in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 134 funds tracked by Wall St. Rank hold VBIV as of Q2 2021.

  • International Assets Investment Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 3 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2021.
  • International Assets Investment Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2021 and held it in 1 quarter.
  • International Assets Investment Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $0 in Q1 2021.
  • 134 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.